Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Stephen Pochebit is active.

Publication


Featured researches published by Stephen Pochebit.


Oral Surgery, Oral Medicine, Oral Pathology | 1988

Multiple dental follicles with odontogenic fibroma-like changes (WHO type)

Howard J. Sandler; Robert R. Nersasian; Edmund Cataldo; Stephen Pochebit; Yogeshwar Dayal

A 15-year-old boy, in the case presented in this article, had 13 unerupted teeth, each associated with hyperplastic pericoronal tissue that showed histologic features suggestive of the WHO type of odontogenic fibroma. The etiology, clinical features, radiographic findings, and histopathology of the odontogenic fibroma are reviewed. It is suggested that the unusual pericoronal findings represent a hamartomatous change.


International Journal of Radiation Oncology Biology Physics | 2013

Impact of Margin Status on Local Recurrence After Mastectomy for Ductal Carcinoma In Situ

Stephanie K. Childs; Yu-Hui Chen; Margaret M. Duggan; Mehra Golshan; Stephen Pochebit; Rinaa S. Punglia; Julia S. Wong; Jennifer R. Bellon

PURPOSE To examine the rate of local recurrence according to the margin status for patients with pure ductal carcinoma in situ (DCIS) treated by mastectomy. METHODS AND MATERIALS One hundred forty-five consecutive women who underwent mastectomy with or without radiation therapy for DCIS from 1998 to 2005 were included in this retrospective analysis. Only patients with pure DCIS were eligible; patients with microinvasion were excluded. The primary endpoint was local recurrence, defined as recurrence on the chest wall; regional and distant recurrences were secondary endpoints. Outcomes were analyzed according to margin status (positive, close (≤2 mm), or negative), location of the closest margin (superficial, deep, or both), nuclear grade, necrosis, receptor status, type of mastectomy, and receipt of hormonal therapy. RESULTS The primary cohort consisted of 142 patients who did not receive postmastectomy radiation therapy (PMRT). For those patients, the median follow-up time was 7.6 years (range, 0.6-13.0 years). Twenty-one patients (15%) had a positive margin, and 23 patients (16%) had a close (≤2 mm) margin. The deep margin was close in 14 patients and positive in 6 patients. The superficial margin was close in 13 patients and positive in 19 patients. One patient experienced an isolated invasive chest wall recurrence, and 1 patient had simultaneous chest wall, regional nodal, and distant metastases. The crude rates of chest wall recurrence were 2/142 (1.4%) for all patients, 1/21 (4.8%) for those with positive margins, 1/23 (4.3%) for those with close margins, and 0/98 for patients with negative margins. PMRT was given as part of the initial treatment to 3 patients, 1 of whom had an isolated chest wall recurrence. CONCLUSIONS Mastectomy for pure DCIS resulted in a low rate of local or distant recurrences. Even with positive or close mastectomy margins, the rates of chest wall recurrences were so low that PMRT is likely not warranted.


International Journal of Radiation Oncology Biology Physics | 2012

Surgical Margins and the Risk of Local-Regional Recurrence After Mastectomy Without Radiation Therapy

Stephanie K. Childs; Yu-Hui Chen; Margaret M. Duggan; Mehra Golshan; Stephen Pochebit; Julia S. Wong; Jennifer R. Bellon

PURPOSE Although positive surgical margins are generally associated with a higher risk of local-regional recurrence (LRR) for most solid tumors, their significance after mastectomy remains unclear. We sought to clarify the influence of the mastectomy margin on the risk of LRR. METHODS AND MATERIALS The retrospective cohort consisted of 397 women who underwent mastectomy and no radiation for newly diagnosed invasive breast cancer from 1998-2005. Time to isolated LRR and time to distant metastasis (DM) were evaluated by use of cumulative-incidence analysis and competing-risks regression analysis. DM was considered a competing event for analysis of isolated LRR. RESULTS The median follow-up was 6.7 years (range, 0.5-12.8 years). The superficial margin was positive in 41 patients (10%) and close (≤2 mm) in 56 (14%). The deep margin was positive in 23 patients (6%) and close in 34 (9%). The 5-year LRR and DM rates for all patients were 2.4% (95% confidence interval, 0.9-4.0) and 3.5% (95% confidence interval, 1.6-5.3) respectively. Fourteen patients had an LRR. Margin status was significantly associated with time to isolated LRR (P=.04); patients with positive margins had a 5-year LRR of 6.2%, whereas patients with close margins and negative margins had 5-year LRRs of 1.5% and 1.9%, respectively. On univariate analysis, positive margins, positive nodes, lymphovascular invasion, grade 3 histology, and triple-negative subtype were associated with significantly higher rates of LRR. When these factors were included in a multivariate analysis, only positive margins and triple-negative subtype were associated with the risk of LRR. CONCLUSIONS Patients with positive mastectomy margins had a significantly higher rate of LRR than those with a close or negative margin. However, the absolute risk of LRR in patients with a positive surgical margin in this series was low, and therefore the benefit of postmastectomy radiation in this population with otherwise favorable features is likely to be small.


Skeletal Radiology | 1989

Case report 525

Eva M. Statz; Stephen Pochebit; Amiel Cooper; Ervin Philipps; Bruce M. Leslie

A 24-year-old women complained of pain in the region of the distal phalanx of the left thumb, with no previous history of trauma. She subsequently noticed swelling deep to the nail plate which was initially thought to represent a paronychia. After an unsuccessful course of oral antibiotics she was referred to a surgeon for evaluation. Initial radiographs of the left thumb (Fig. 1) demonstrate a localized expansile area of osteolysis without marginal sclerosis destroying the radial cortex of the distal phalanx. Neither the articular surface or the joint are involved. There is no visibe matrix nor evidence of periosteal reaction. The soft tissues surrounding the phalanx are swollen. The patient underwent curettage and bone grafting from the ipsilateral proximal ulna to the distal phalanx of the thumb. Recurrence of the lesion was manifest within 4 months following curettage. Radiographs showed almost complete dissolution of the bony contour of the distal phalanx and destruction of the bone graft. A bone scan showed increased uptake in the distal portion of the proximal phalanx and the distal phalanx. Partial amputation of the thumb was carried out.


Applied Clinical Informatics | 2018

Semiautomated System for Nonurgent, Clinically Significant Pathology Results

Ramin Khorasani; Stephen Pochebit; Ronilda Lacson; Katherine P. Andriole; Anuj K. Dalal; Stacy O'Connor

BACKGROUND Failure of timely test result follow-up has consequences including delayed diagnosis and treatment, added costs, and potential patient harm. Closed-loop communication is key to ensure clinically significant test results (CSTRs) are acknowledged and acted upon appropriately. A previous implementation of the Alert Notification of Critical Results (ANCR) system to facilitate closed-loop communication of imaging CSTRs yielded improved communication of critical radiology results and enhanced adherence to institutional CSTR policies. OBJECTIVE This article extends the ANCR application to pathology and evaluates its impact on closed-loop communication of new malignancies, a common and important type of pathology CSTR. MATERIALS AND METHODS This Institutional Review Board-approved study was performed at a 150-bed community, academically affiliated hospital. ANCR was adapted for pathology CSTRs. Natural language processing was used on 30,774 pathology reports 13 months pre- and 13 months postintervention, identifying 5,595 reports with malignancies. Electronic health records were reviewed for documented acknowledgment for a random sample of reports. Percent of reports with documented acknowledgment within 15 days assessed institutional policy adherence. Time to acknowledgment was compared pre- versus postintervention and postintervention with and without ANCR alerts. Pathologists were surveyed regarding ANCR use and satisfaction. RESULTS Acknowledgment within 15 days was documented for 98 of 107 (91.6%) pre- and 89 of 103 (86.4%) postintervention reports (p = 0.2294). Median time to acknowledgment was 7 days (interquartile range [IQR], 3, 11) preintervention and 6 days (IQR, 2, 10) postintervention (p = 0.5083). Postintervention, median time to acknowledgment was 2 days (IQR, 1, 6) for reports with ANCR alerts versus 6 days (IQR, 2.75, 9) for reports without alerts (p = 0.0351). ANCR alerts were sent on 15 of 103 (15%) postintervention reports. All pathologists reported that the ANCR system positively impacted their workflow; 75% (three-fourths) felt that the ANCR system improved efficiency of communicating CSTRs. CONCLUSION ANCR expansion to facilitate closed-loop communication of pathology CSTRs was favorably perceived and associated with significant improved time to documented acknowledgment for new malignancies. The rate of adherence to institutional policy did not improve.


Journal of Oncology Practice | 2017

Implementation of Surgeon-Initiated Gene Expression Profile Testing (Oncotype DX) Among Patients With Early-Stage Breast Cancer to Reduce Delays in Chemotherapy Initiation

Katya Losk; Rachel A. Freedman; Nan Lin; Mehra Golshan; Stephen Pochebit; Susan Lester; Kelsey Natsuhara; Kristen Camuso; Tari A. King; Craig A. Bunnell

PURPOSE Delays to adjuvant chemotherapy initiation in breast cancer may adversely affect clinical outcomes and patient satisfaction. We previously identified an association between genomic testing (Onco type DX) and delayed chemotherapy initiation. We sought to reduce the interval between surgery and adjuvant chemotherapy initiation by developing standardized criteria and workflows for Onco type DX testing. METHODS Criteria for surgeon-initiated reflex Onco type DX testing, workflows for communication between surgeons and medical oncologists, and a streamlined process for receiving and processing Onco type DX requests in pathology were established by multidisciplinary consensus. Criteria for surgeon-initiated testing included patients ≤ 65 years old with T1cN0 (grade 2 or 3), T2N0 (grade 1 or 2), or T1/T2N1 (grade 1 or 2) breast cancer on final surgical pathology. Medical oncologists could elect to initiate Onco type testing for cases falling outside the criteria. We then examined 720 consecutive patients with breast cancer who underwent Onco type DX testing postoperatively between January 1, 2014 and November 28, 2016 and measured intervals between date of surgery, Onco type DX order date, result received date, and chemotherapy initiation date (if applicable) before and after intervention implementation. RESULTS The introduction of standardized criteria and workflows reduced time between surgery and Onco type DX ordering, and time from surgery to receipt of result, by 7.3 days ( P < .001) and 6.3 days ( P < .001), respectively. The mean number of days between surgery and initiation of chemotherapy was also reduced by 6.4 days ( P = .004). CONCLUSION Developing consensus on Onco type DX testing criteria and implementing streamlined workflows has led to clinically significant reductions in wait times to chemotherapy decision making and initiation.


Journal of Clinical Oncology | 2011

Surgical margins and the risk of local-regional recurrence (LRR) following mastectomy for early-stage breast cancer.

Stephanie K. Childs; Y. Chen; Stephen Pochebit; Mehra Golshan; Margaret M. Duggan; J.S. Wong; Jay R. Harris; Jennifer R. Bellon

95 Background: We sought to clarify the influence of a positive or close superficial or deep mastectomy margin on the risk of LRR. Methods: We reviewed the charts of 561 consecutive women who underwent mastectomy without radiation for newly diagnosed in situ or invasive breast cancer between 1998 and 2005. The study cohort consists of 167 of these women who had a positive or close (≤2 mm) superficial or deep surgical margin. LRR as the site of first recurrence (+/− simultaneous distant disease) and distant metastasis (DM) rates were calculated using the Kaplan-Meier method. The median age was 50 years. Forty-five (27%) had ductal carcinoma in situ (DCIS) only. Of the 122 women with invasive disease, 79% had T1, 18% T2, and 3% T3 tumors, and 25% had positive axillary nodes (range, 1-4; 68% 1 positive node). Twenty-nine (24%) of those with invasive disease had lymphovascular invasion. The superficial margin was positive in 61 (37%) and close in 69 (41%). The deep margin was positive in 28 (17%) and close in...


Breast Cancer Research and Treatment | 2012

Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort.

Serena Masciari; Deborah A. Dillon; Michelle Rath; Mark E. Robson; Jeffrey N. Weitzel; Judith Balmaña; Stephen B. Gruber; James M. Ford; David M. Euhus; Alexandra Lebensohn; Melinda L. Telli; Stephen Pochebit; Georgios Lypas; Judy Garber


Oncologist | 2018

Impact of Genomic Assay Testing and Clinical Factors on Chemotherapy Use After Implementation of Standardized Testing Criteria

Kelsey Natsuhara; Katya Losk; Tari A. King; Nan Lin; Kristen Camuso; Mehra Golshan; Stephen Pochebit; Jane E. Brock; Craig A. Bunnell; Rachel A. Freedman


Nature Communications | 2018

Galectin-9 suppresses B cell receptor signaling and is regulated by I-branching of N-glycans

Nicholas Giovannone; Jennifer Liang; Aristotelis Antonopoulos; J. Geddes Sweeney; Sandra L. King; Stephen Pochebit; Neil Bhattacharyya; G. S. Lee; Anne Dell; Hans R. Widlund; Stuart M. Haslam; Charles J. Dimitroff

Collaboration


Dive into the Stephen Pochebit's collaboration.

Top Co-Authors

Avatar

Mehra Golshan

Brigham and Women's Hospital

View shared research outputs
Top Co-Authors

Avatar

Jennifer R. Bellon

Brigham and Women's Hospital

View shared research outputs
Top Co-Authors

Avatar

Margaret M. Duggan

Brigham and Women's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

J.S. Wong

Brigham and Women's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge